CLINICAL_TRIALS
trial_result
· 2014-10-24
Clinical Trial Update: Effects of Eslicarbazepine Acetate (Esl, Bia 2-093) on Cognitive Function in Children With Partial Onset Seizures [Phase 2]
Summary
Phase 2 study evaluating the cognitive effects of eslicarbazepine acetate in children with partial-onset seizures; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bial - Portela C S.A. | Conditions: Partial Epilepsy | Phase 2 | Status: COMPLETED | Results posted: 2014-10-24